{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:47:42Z","timestamp":1790995662513,"version":"4.1.0"},"reference-count":129,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.addr.2023.114868","type":"journal-article","created":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T02:10:36Z","timestamp":1683857436000},"page":"114868","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Trans-corneal drug delivery strategies in the treatment of ocular diseases"],"prefix":"10.1016","volume":"198","author":[{"given":"Liping","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghuai","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2023.114868_b0005","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1111\/bph.14024","article-title":"Principles of pharmacology in the eye","volume":"174","author":"Awwad","year":"2017","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.addr.2023.114868_b0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.addr.2017.04.001","article-title":"Nanoparticles for drug delivery to the anterior segment of the eye","volume":"122","author":"Janagam","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.addr.2023.114868_b0015","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1124\/jpet.119.256933","article-title":"Ocular Drug Delivery: Present Innovations and Future Challenges","volume":"370","author":"Gote","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.addr.2023.114868_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108115","article-title":"Biological functions of tear film","volume":"197","author":"Pflugfelder","year":"2020","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.addr.2023.114868_b0025","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4103\/ijo.IJO_646_17","article-title":"Anatomy of cornea and ocular surface","volume":"66","author":"Sridhar","year":"2018","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.addr.2023.114868_b0030","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1517\/17425255.2011.562195","article-title":"In vitro cell culture models to study the corneal drug absorption","volume":"7","author":"Reichl","year":"2011","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.addr.2023.114868_b0035","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jconrel.2012.01.019","article-title":"Liposomes for Intravitreal Drug Delivery: A State of the Art","volume":"161","author":"Bochot","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2023.114868_b0040","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.2147\/OPTH.S165722","article-title":"Intracameral Dexamethasone Injection in the Treatment of Cataract Surgery Induced Inflammation: Design, Development, and Place in Therapy","volume":"12","author":"Shah","year":"2018","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.addr.2023.114868_b0045","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.addr.2006.07.027","article-title":"Challenges and obstacles of ocular pharmacokinetics and drug delivery","volume":"58","author":"Urtti","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.addr.2023.114868_b0050","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.addr.2006.07.024","article-title":"Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics","volume":"58","author":"Mannermaa","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.addr.2023.114868_b0055","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jconrel.2017.01.012","article-title":"Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies","volume":"248","author":"Mandal","year":"2017","journal-title":"J Control Release"},{"key":"10.1016\/j.addr.2023.114868_b0060","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3390\/gels8020082","article-title":"Drug Delivery Challenges and Current Progress in Nanocarrier-Based Ocular Therapeutic System","volume":"8","author":"Akhter","year":"2022","journal-title":"Gels"},{"key":"10.1016\/j.addr.2023.114868_b0065","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.drudis.2021.02.027","article-title":"Advanced nanodelivery platforms for topical ophthalmic drug delivery","volume":"26","author":"Gholizadeh","year":"2021","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.addr.2023.114868_b0070","doi-asserted-by":"crossref","first-page":"2109865","DOI":"10.1002\/adma.202109865","article-title":"Engineering Hibiscus-Like Riboflavin\/ZIF-8 Microsphere Composites to Enhance Transepithelial Corneal Cross-Linking","volume":"34","author":"Yang","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2023.114868_b0075","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/17425247.2016.1198766","article-title":"Ultrasound-mediated ocular delivery of therapeutic agents: a review","volume":"14","author":"Lafond","year":"2017","journal-title":"Expert Opin Drug Deliv."},{"key":"10.1016\/j.addr.2023.114868_b0080","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jconrel.2005.09.049","article-title":"Iontophoresis: A non-invasive ocular drug delivery","volume":"110","author":"Eljarrat-Binstock","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2023.114868_b0085","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.addr.2012.04.005","article-title":"Microneedles for drug and vaccine delivery","volume":"64","author":"Kim","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2023.114868_b0090","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1167\/iovs.07-0066","article-title":"Coated microneedles for drug delivery to the eye","volume":"48","author":"Jiang","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.addr.2023.114868_b0095","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jconrel.2015.04.041","article-title":"Impact insertion of transfer-molded microneedle for localized and minimally invasive ocular drug delivery","volume":"209","author":"Song","year":"2015","journal-title":"J Control Release"},{"key":"10.1016\/j.addr.2023.114868_b0100","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.3109\/03639045.2012.736515","article-title":"Recent advances in ocular drug delivery","volume":"39","author":"Achouri","year":"2013","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.addr.2023.114868_b0105","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.addr.2006.07.026","article-title":"Intraocular implants for extended drug delivery: therapeutic applications","volume":"58","author":"Bourges","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.addr.2023.114868_b0110","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0002-9394(98)00443-7","article-title":"Visual and anatomic outcomes associated with posterior segment complications after ganciclovir implant procedures in patients with AIDS and cytomegalovirus retinitis","volume":"127","author":"Lim","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.addr.2023.114868_b0115","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1089\/1080768041223611","article-title":"Ocular pharmacokinetics of fluocinolone acetonide after Retisert intravitreal implantation in rabbits over a 1-year period","volume":"20","author":"Driot","year":"2004","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.addr.2023.114868_b0120","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/s41433-020-0809-0","article-title":"Advances in ocular drug delivery systems","volume":"34","author":"Kang-Mieler","year":"2020","journal-title":"Eye (Lond)"},{"issue":"57","key":"10.1016\/j.addr.2023.114868_b0125","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1167\/iovs.16-19585","article-title":"Biocompatibility and Pharmacokinetic Analysis of an Intracameral Polycaprolactone Drug Delivery Implant for Glaucoma","volume":"2016","author":"Kim","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.addr.2023.114868_b0130","doi-asserted-by":"crossref","first-page":"444","DOI":"10.2174\/1567201816666190201143457","article-title":"Topical and Transdermal Drug Delivery: From Simple Potions to Smart Technologies","volume":"16","author":"Benson","year":"2019","journal-title":"Curr Drug Deliv"},{"key":"10.1016\/j.addr.2023.114868_b0135","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.actbio.2019.01.004","article-title":"Effect of gold nanoparticles on timolol uptake and its release kinetics from contact lenses: In vitro and in vivo evaluation","volume":"86","author":"Maulvi","year":"2019","journal-title":"Acta Biomater"},{"key":"10.1016\/j.addr.2023.114868_b0140","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/j.ophtha.2016.06.038","article-title":"Latanoprost-Eluting Contact Lenses in Glaucomatous Monkeys","volume":"123","author":"Ciolino","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.addr.2023.114868_b0145","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jconrel.2012.10.010","article-title":"Glaucoma therapy by extended release of timolol from nanoparticle loaded silicone-hydrogel contact lenses","volume":"165","author":"Jung","year":"2013","journal-title":"J Control Release"},{"key":"10.1016\/j.addr.2023.114868_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114770","article-title":"Polymer- and lipid-based nanocarriers for ocular drug delivery: Current status and future perspectives","volume":"196","author":"Han","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2023.114868_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-4274(01)00261-2","article-title":"Saettone Cytotoxicity of potential ocular permeation enhancers evaluated on rabbit and human corneal epithelial cell lines","volume":"122","author":"Burgalassi","year":"2001","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.addr.2023.114868_b0160","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/00003226-200107000-00013","article-title":"Effects of three penetration enhancers on transcorneal permeation of cyclosporine","volume":"20","author":"van der Bijl","year":"2001","journal-title":"Cornea"},{"key":"10.1016\/j.addr.2023.114868_b0165","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1034\/j.1601-0825.2002.01821.x","article-title":"Enhancement of transmucosal permeation of cyclosporine by benzalkonium chloride","volume":"8","author":"van der Bijl","year":"2002","journal-title":"Oral Dis"},{"key":"10.1016\/j.addr.2023.114868_b0170","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12325-008-0019-9","article-title":"Ocular distribution, bactericidal activity and settling characteristics of TobraDex ST ophthalmic suspension compared with TobraDex ophthalmic suspension","volume":"25","author":"Scoper","year":"2008","journal-title":"Adv Ther"},{"key":"10.1016\/j.addr.2023.114868_b0175","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/604204","article-title":"Successfully improving ocular drug delivery using the cationic nanoemulsion novasorb","volume":"2012","author":"Lallemand","year":"2012","journal-title":"J Drug Deliv."},{"key":"10.1016\/j.addr.2023.114868_b0180","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clinthera.2010.12.004","article-title":"Efficacy and tolerability of besifloxacin ophthalmic suspension 0.6% administered twice daily for 3 days in the treatment of bacterial conjunctivitis: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study in adults and children","volume":"33","author":"Silverstein","year":"2011","journal-title":"Clin Ther"},{"key":"10.1016\/j.addr.2023.114868_b0185","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.ophtha.2012.06.052","article-title":"and Rebamipide Ophthalmic Suspension Phase II Study Group, Rebamipide (OPC-12759) in the treatment of dry eye: a randomized, double-masked, multicenter, placebo-controlled phase II study","volume":"119","author":"Kinoshita","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.addr.2023.114868_b0190","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3390\/ph14111201","article-title":"Cellulosic Polymers for Enhancing Drug Bioavailability in Ocular Drug Delivery Systems","volume":"14","author":"Gupta","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.addr.2023.114868_b0195","doi-asserted-by":"crossref","DOI":"10.3390\/gels7030130","article-title":"Gel-Based Materials for Ophthalmic Drug Delivery","volume":"7","author":"Cassano","year":"2021","journal-title":"Gels"},{"key":"10.1016\/j.addr.2023.114868_b0200","doi-asserted-by":"crossref","first-page":"e2003699","DOI":"10.1002\/advs.202003699","article-title":"Ocular nanomedicine","volume":"9","author":"Tang","year":"2022","journal-title":"Adv Sci (Weinh)."},{"key":"10.1016\/j.addr.2023.114868_b0205","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.addr.2021.01.005","article-title":"Jun Recent advances in nanomaterials for therapy and diagnosis for atherosclerosis","volume":"170","author":"Chen","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2023.114868_b0210","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ejpb.2015.02.019","article-title":"Nanotherapies for the treatment of ocular diseases","volume":"95","author":"Reimondez-Troitino","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.addr.2023.114868_b0215","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212368","article-title":"Nanotechnology for Topical Drug Delivery to the Anterior Segment of the Eye","volume":"22","author":"Vaneev","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.addr.2023.114868_b0220","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3390\/nano10040720","article-title":"Dexibuprofen Biodegradable Nanoparticles: One Step Closer towards a Better Ocular Interaction Study","volume":"10","author":"Sanchez-Lopez","year":"2020","journal-title":"Nanomaterials (Basel)"},{"key":"10.1016\/j.addr.2023.114868_b0225","first-page":"37","article-title":"Nanoencapsulated Hybrid Compound SA-2 with Long-Lasting Intraocular Pressure-Lowering Activity in Rodent Eyes","volume":"27","author":"Stankowska","year":"2021","journal-title":"Mol Vis"},{"key":"10.1016\/j.addr.2023.114868_b0230","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ijpharm.2011.01.004","article-title":"Ocular Biocompatibility of Novel Cyclosporin A Formulations Based on Methoxy Poly(ethylene glycol)-hexylsubstituted poly(lactide) Micelle Carriers","volume":"416","author":"Di Tommaso","year":"2011","journal-title":"Int J Pharm"},{"key":"10.1016\/j.addr.2023.114868_b0235","doi-asserted-by":"crossref","first-page":"e2004205","DOI":"10.1002\/smll.202004205","article-title":"Targeted Delivery of Cell Softening Micelles to Schlemm's Canal Endothelial Cells for Treatment of Glaucoma","volume":"16","author":"Stack","year":"2020","journal-title":"Small"},{"key":"10.1016\/j.addr.2023.114868_b0240","article-title":"Brinzolamide loaded core-shell nanoparticles for enhanced coronial penetration in the treatment of glaucoma","volume":"18","author":"Song","year":"2020","journal-title":"J Appl Biomater Funct Mater"},{"key":"10.1016\/j.addr.2023.114868_b0245","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.biopha.2017.07.110","article-title":"Aws Alshamsan, Poly(d, l-lactide-co-glycolide) nanoparticles for sustained release of tacrolimus in rabbit eyes","volume":"94","author":"Mohd Abul Kalam","year":"2017","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/j.addr.2023.114868_b0250","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2147\/IJN.S332127","article-title":"Thermosensitive Tri-block polymer nanoparticle-hydrogel composites as Payloads of natamycin for antifungal therapy against fusarium solani","volume":"17","author":"Sha","year":"2022","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.addr.2023.114868_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.105748","article-title":"Latanoprost-loaded phytantriol cubosomes for the treatment of glaucoma","volume":"160","author":"Bessone","year":"2021","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.addr.2023.114868_b0260","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1167\/tvst.5.6.12","article-title":"Endophthalmitis Prophylaxis Using a Single Drop of Thermoresponsive Controlled-Release Microspheres Loaded with Moxifloxacin in a Rabbit Model","volume":"5","author":"Mammen","year":"2016","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.addr.2023.114868_b0265","doi-asserted-by":"crossref","first-page":"8639","DOI":"10.1038\/s41598-017-09379-8","article-title":"Long Term Glaucoma Drug Delivery Using a Topically Retained Gel\/Microsphere Eye Drop","volume":"7","author":"Fedorchak","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.addr.2023.114868_b0270","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1021\/acs.molpharmaceut.7b00291","article-title":"Hydrophobically Modified Polymer\/alpha-Cyclodextrin Thermoresponsive Hydrogels for Use in Ocular Drug Delivery","volume":"14","author":"Iohara","year":"2017","journal-title":"Mol Pharm"},{"key":"10.1016\/j.addr.2023.114868_b0275","first-page":"4294","article-title":"The Monthly Eye Drop: Development of a Long-term, Noninvasive Glaucoma Treatment System","volume":"54","author":"Fedorchak","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.addr.2023.114868_b0280","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1039\/C8TB02976H","article-title":"Tuning of thermoresponsive pNIPAAm hydrogels for the topical retention of controlled release ocular therapeutics","volume":"7","author":"Bellotti","year":"2019","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.addr.2023.114868_b0285","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1021\/bm301742m","article-title":"Developing the potential ophthalmic applications of pilocarpine entrapped into polyvinylpyrrolidone-poly(acrylic acid) nanogel dispersions prepared by gamma radiation","volume":"14","author":"Abd El-Rehim","year":"2013","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2023.114868_b0290","doi-asserted-by":"crossref","first-page":"11066","DOI":"10.1038\/s41598-018-29393-8","article-title":"Topical Curcumin Nanocarriers are Neuroprotective in Eye Disease","volume":"8","author":"Davis","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.addr.2023.114868_b0295","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1080\/17425247.2021.1872542","article-title":"Liposomes as vehicles for topical ophthalmic drug delivery and ocular surface protection","volume":"18","author":"Lopez-Cano","year":"2021","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.addr.2023.114868_b0300","first-page":"123","article-title":"Nanomedicine for glaucoma: liposomes provide sustained release of latanoprost in the eye","volume":"7","author":"Natarajan","year":"2012","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.addr.2023.114868_b0305","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.3109\/10717544.2014.943336","article-title":"Liposomes in topical ophthalmic drug delivery: an update","volume":"23","author":"Agarwal","year":"2016","journal-title":"Drug Deliv"},{"key":"10.1016\/j.addr.2023.114868_b0310","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1021\/nn4046024","article-title":"Sustained drug release in nanomedicine: a long-acting nanocarrier-based formulation for glaucoma","volume":"8","author":"Natarajan","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2023.114868_b0315","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ijpharm.2018.07.012","article-title":"Treatment merits of Latanoprost\/Thymoquinone - Encapsulated liposome for glaucomatus rabbits","volume":"548","author":"Fahmy","year":"2018","journal-title":"Int J Pharm"},{"key":"10.1016\/j.addr.2023.114868_b0320","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1208\/s12249-015-0382-1","article-title":"Liposomes as a Novel Ocular Delivery System for Brinzolamide","volume":"17","author":"Li","year":"2016","journal-title":"In Vitro and In Vivo Studies, AAPS PharmSciTech"},{"key":"10.1016\/j.addr.2023.114868_b0325","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2174\/138920012798356934","article-title":"PEGylation of proteins and liposomes: a powerful and flexible strategy to improve the drug delivery","volume":"13","author":"Milla","year":"2012","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.addr.2023.114868_b0330","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/ard.2003.009944","article-title":"Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis","volume":"63","author":"Metselaar","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.addr.2023.114868_b0335","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1002\/art.11140","article-title":"Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes","volume":"48","author":"Metselaar","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.addr.2023.114868_b0340","doi-asserted-by":"crossref","first-page":"6604","DOI":"10.1038\/s41598-018-24545-2","article-title":"Evaluation of subconjunctival liposomal steroids for the treatment of experimental uveitis","volume":"8","author":"Wong","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.addr.2023.114868_b0345","doi-asserted-by":"crossref","first-page":"2003775","DOI":"10.1002\/advs.202003775","article-title":"Rationally Programming Nanomaterials with DNA for Biomedical Applications","volume":"8","author":"He","year":"2021","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.addr.2023.114868_b0350","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.biomaterials.2017.11.046","article-title":"DNA nanoparticles for ophthalmic drug delivery","volume":"157","author":"Willem de Vries","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2023.114868_b0355","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.addr.2010.03.005","article-title":"DNA self-assembly for nanomedicine","volume":"62","author":"Chhabra","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.addr.2023.114868_b0360","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nature07971","article-title":"Self-assembly of a nanoscale DNA box with a controllable lid","volume":"459","author":"Andersen","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.addr.2023.114868_b0365","article-title":"Self-assembled DNA nanoparticles loaded with travoprost for glaucoma-treatment","volume":"29","author":"Schnichels","year":"2020","journal-title":"Nanomedicine"},{"key":"10.1016\/j.addr.2023.114868_b0370","doi-asserted-by":"crossref","first-page":"9445","DOI":"10.1021\/acsami.0c18626","article-title":"Improved Treatment Options for Glaucoma with Brimonidine-Loaded Lipid DNA Nanoparticles","volume":"13","author":"Schnichels","year":"2021","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.addr.2023.114868_b0375","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10040197","article-title":"Formulation and Characterization of Carvedilol Leciplex for Glaucoma Treatment: In-Vitro, Ex-Vivo and In-Vivo Study","volume":"10","author":"Hassan","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2023.114868_b0380","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijpharm.2014.11.032","article-title":"Cationic solid lipid nanoparticles enhance ocular hypotensive effect of melatonin in rabbit","volume":"478","author":"Leonardi","year":"2015","journal-title":"Int J Pharm"},{"key":"10.1016\/j.addr.2023.114868_b0385","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1517\/17425247.2013.736962","article-title":"Eudragit: a technology evaluation","volume":"10","author":"Thakral","year":"2013","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.addr.2023.114868_b0390","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3109\/10717544.2013.834417","article-title":"Development, in vitro and in vivo characterization of Eudragit RL 100 nanoparticles for improved ocular bioavailability of acetazolamide","volume":"20","author":"Verma","year":"2013","journal-title":"Drug Deliv"},{"key":"10.1016\/j.addr.2023.114868_b0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.clay.2019.105167","article-title":"Dual controlled release effect of montmorillonite loaded polymer nanoparticles for ophthalmic drug delivery","volume":"180","author":"Zhao","year":"2019","journal-title":"Appl. Clay Sci."},{"key":"10.1016\/j.addr.2023.114868_b0400","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.addr.2006.03.001","article-title":"Natural polymers for gene delivery and tissue engineering","volume":"58","author":"Dang","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2023.114868_b0405","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3109\/10837450.2014.999786","article-title":"Gelatin-based particulate systems in ocular drug delivery","volume":"21","author":"Hathout","year":"2016","journal-title":"Pharm Dev Technol"},{"key":"10.1016\/j.addr.2023.114868_b0410","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ijpharm.2018.04.059","article-title":"Exploring gelatin nanoparticles as novel nanocarriers for Timolol Maleate: Augmented in-vivo efficacy and safe histological profile","volume":"545","author":"Shokry","year":"2018","journal-title":"Int J Pharm"},{"key":"10.1016\/j.addr.2023.114868_b0415","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3390\/pharmaceutics12040306","article-title":"Gelatin nanoparticles-HPMC hybrid system for effective ocular topical administration of antihypertensive agents","volume":"12","author":"Esteban-P\u00e9rez","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2023.114868_b0420","doi-asserted-by":"crossref","DOI":"10.3390\/md20020151","article-title":"Chitosan and Hyaluronic Acid Nanoparticles as Vehicles of Epoetin Beta for Subconjunctival Ocular Delivery","volume":"20","author":"Silva","year":"2022","journal-title":"Mar Drugs"},{"key":"10.1016\/j.addr.2023.114868_b0425","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1167\/tvst.4.3.12","article-title":"Natural Bioadhesive Biodegradable Nanoparticle-Based Topical Ophthalmic Formulations for Management of Glaucoma","volume":"4","author":"Ibrahim","year":"2015","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.addr.2023.114868_b0430","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ejps.2012.08.008","article-title":"Chitosan coated sodium alginate-chitosan nanoparticles loaded with 5-FU for ocular delivery: in vitro characterization and in vivo study in rabbit eye","volume":"47","author":"Nagarwal","year":"2012","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.addr.2023.114868_b0435","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.ijbiomac.2017.11.090","article-title":"Nanogel-based natural polymers as smart carriers for the controlled delivery of Timolol Maleate through the cornea for glaucoma","volume":"109","author":"Ilka","year":"2018","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.addr.2023.114868_b0440","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1016\/j.xphs.2018.08.015","article-title":"Chitosan-Gelatin Hydrogel Crosslinked with Oxidized Sucrose for the Ocular Delivery of Timolol Maleate","volume":"107","author":"El-Feky","year":"2018","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.addr.2023.114868_b0445","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1021\/acs.chemrev.8b00401","article-title":"Versatile Types of Organic\/Inorganic Nanohybrids: From Strategic Design to Biomedical Applications","volume":"119","author":"Zhao","year":"2019","journal-title":"Chem Rev"},{"key":"10.1016\/j.addr.2023.114868_b0450","doi-asserted-by":"crossref","first-page":"8036","DOI":"10.1167\/iovs.12-10743","article-title":"Effects of gold nanoparticles on endotoxin-induced uveitis in rats","volume":"53","author":"Pereira","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.addr.2023.114868_b0455","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/med.21509","article-title":"Gold nanoparticles in ophthalmology","volume":"39","author":"Masse","year":"2019","journal-title":"Med Res Rev"},{"key":"10.1016\/j.addr.2023.114868_b0460","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201700831","article-title":"Mesoporous Silica and Organosilica Nanoparticles: Physical Chemistry, Biosafety, Delivery Strategies, and Biomedical Applications","volume":"7","author":"Croissant","year":"2018","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.addr.2023.114868_b0465","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1002\/adma.201205292","article-title":"In vivo bio-safety evaluations and diagnostic\/therapeutic applications of chemically designed mesoporous silica nanoparticles","volume":"25","author":"Chen","year":"2013","journal-title":"Adv Mater"},{"key":"10.1016\/j.addr.2023.114868_b0470","doi-asserted-by":"crossref","first-page":"e1801047","DOI":"10.1002\/adhm.201801047","article-title":"Local Delivery and Sustained-Release of Nitric Oxide Donor Loaded in Mesoporous Silica Particles for Efficient Treatment of Primary Open-Angle Glaucoma","volume":"7","author":"Hu","year":"2018","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.addr.2023.114868_b0475","doi-asserted-by":"crossref","first-page":"7008","DOI":"10.1039\/C7TB01217A","article-title":"Gelatin-functionalized mesoporous silica nanoparticles with sustained release properties for intracameral pharmacotherapy of glaucoma","volume":"5","author":"Liao","year":"2017","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.addr.2023.114868_b0480","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19010282","article-title":"Enhancement in Corneal Permeability of Dissolved Carteolol by Its Combination with Magnesium Hydroxide Nanoparticles","volume":"19","author":"Nagai","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.addr.2023.114868_b0485","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.exer.2017.10.002","article-title":"Co-instillation of nano-solid magnesium hydroxide enhances corneal permeability of dissolved timolol","volume":"165","author":"Nagai","year":"2017","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.addr.2023.114868_b0490","article-title":"Magnesium Hydroxide Nanoparticles Improve the Ocular Hypotensive Effect of Twice Daily Topical Timolol Maleate in Healthy Dogs","volume":"8","author":"Kita","year":"2021","journal-title":"Vet Sci"},{"key":"10.1016\/j.addr.2023.114868_b0495","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1016\/j.biomaterials.2011.03.056","article-title":"Mechanism and consequence of chitosan-mediated reversible epithelial tight junction opening","volume":"32","author":"Yeh","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2023.114868_b0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119961","article-title":"Duc Dung Nguyen, Jui-Yang Lai, Dually functional hollow ceria nanoparticle platform for intraocular drug delivery: A push beyond the limits of static and dynamic ocular barriers toward glaucoma therapy","volume":"243","author":"Luo","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2023.114868_b0505","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ijbiomac.2018.04.122","article-title":"Ali, Chitosan coated PLGA nanoparticles amplify the ocular hypotensive effect of forskolin: Statistical design, characterization and in vivo studies","volume":"116","author":"Khan","year":"2018","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.addr.2023.114868_b0510","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1208\/s12249-015-0448-0","article-title":"A Novel Method for Preparing Surface-Modified Fluocinolone Acetonide Loaded PLGA Nanoparticles for Ocular Use","volume":"17","author":"Salama","year":"2016","journal-title":"In Vitro and In Vivo Evaluations, AAPS PharmSciTech"},{"key":"10.1016\/j.addr.2023.114868_b0515","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1016\/j.ijbiomac.2020.09.185","article-title":"Optimization to development of chitosan decorated polycaprolactone nanoparticles for improved ocular delivery of dorzolamide: In vitro, ex vivo and toxicity assessments","volume":"163","author":"Shahab","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.addr.2023.114868_b0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118217","article-title":"Chitosan coated nanoparticles for efficient delivery of bevacizumab in the posterior ocular tissues via subconjunctival administration","volume":"267","author":"Pandit","year":"2021","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.addr.2023.114868_b0525","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ijbiomac.2014.02.002","article-title":"Ali, Chitosan nanoparticles amplify the ocular hypotensive effect of cateolol in rabbits","volume":"65","author":"Ameeduzzafar","year":"2014","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.addr.2023.114868_b0530","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2174\/1567201811310050001","article-title":"Betaxolol hydrochloride loaded chitosan nanoparticles for ocular delivery and their anti-glaucoma efficacy","volume":"10","author":"Jain","year":"2013","journal-title":"Curr Drug Deliv"},{"key":"10.1016\/j.addr.2023.114868_b0535","first-page":"308","article-title":"Nanodelivery of triamcinolone acetonide with PLGA-chitosan nanoparticles for the treatment of ocular inflammation, Artif Cells Nanomed","volume":"49","author":"Xing","year":"2021","journal-title":"Biotechnol"},{"key":"10.1016\/j.addr.2023.114868_b0540","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1208\/s12249-016-0669-x","article-title":"Development of Timolol-Loaded Galactosylated Chitosan Nanoparticles and Evaluation of Their Potential for Ocular Drug Delivery","volume":"18","author":"Zhao","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.addr.2023.114868_b0545","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejps.2015.04.003","article-title":"Evaluation of cationic nanosystems with melatonin using an eye-related bioavailability prediction model","volume":"75","author":"Hafner","year":"2015","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.addr.2023.114868_b0550","first-page":"550","article-title":"Topical delivery of acetazolamide by encapsulating in mucoadhesive nanoparticles, Asian","volume":"12","author":"Manchanda","year":"2017","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.addr.2023.114868_b0555","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40199-015-0132-7","article-title":"Improved intraocular bioavailability of ganciclovir by mucoadhesive polymer based ocular microspheres: development and simulation process in Wistar rats","volume":"23","author":"Kapanigowda","year":"2015","journal-title":"Daru"},{"key":"10.1016\/j.addr.2023.114868_b0560","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/02652048.2013.805839","article-title":"Chitosan nanoparticles for ocular delivery of cyclosporine A","volume":"31","author":"Basaran","year":"2014","journal-title":"J Microencapsul"},{"key":"10.1016\/j.addr.2023.114868_b0565","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1080\/10717544.2022.2058648","article-title":"Chitosan-coated bovine serum albumin nanoparticles for topical tetrandrine delivery in glaucoma: in vitro and in vivo assessment","volume":"29","author":"Radwan","year":"2022","journal-title":"Drug Deliv"},{"key":"10.1016\/j.addr.2023.114868_b0570","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/562727","article-title":"Development of dorzolamide loaded 6-o-carboxymethyl chitosan nanoparticles for open angle glaucoma","volume":"2013","author":"Shinde","year":"2013","journal-title":"J Drug Deliv"},{"key":"10.1016\/j.addr.2023.114868_b0575","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.ijbiomac.2019.10.219","article-title":"Brinzolamide loaded chitosan-pectin mucoadhesive nanocapsules for management of glaucoma: Formulation, characterization and pharmacodynamic study","volume":"152","author":"Dubey","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.addr.2023.114868_b0580","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3109\/1061186X.2013.771778","article-title":"Hyperbranched dendritic nano-carriers for topical delivery of dithranol","volume":"21","author":"Agrawal","year":"2013","journal-title":"J Drug Target"},{"key":"10.1016\/j.addr.2023.114868_b0585","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1021\/acs.jmedchem.5b00383","article-title":"Poly(amidoamine) Dendrimers with Carbonic Anhydrase Inhibitory Activity and Antiglaucoma Action","volume":"58","author":"Carta","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.addr.2023.114868_b0590","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1021\/acs.molpharmaceut.8b00401","article-title":"DenTimol as A Dendrimeric Timolol Analogue for Glaucoma Therapy: Synthesis and Preliminary Efficacy and Safety Assessment","volume":"15","author":"Lancina","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1016\/j.addr.2023.114868_b0595","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ijpharm.2013.11.043","article-title":"Acetazolamide encapsulated dendritic nano-architectures for effective glaucoma management in rabbits","volume":"461","author":"Mishra","year":"2014","journal-title":"Int J Pharm"},{"key":"10.1016\/j.addr.2023.114868_b0600","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1166\/jbn.2017.2436","article-title":"Mildly Cross-Linked Dendrimer Hydrogel Prepared via Aza-Michael Addition Reaction for Topical Brimonidine Delivery","volume":"13","author":"Wang","year":"2017","journal-title":"J Biomed Nanotechnol"},{"key":"10.1016\/j.addr.2023.114868_b0605","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nbt1292","article-title":"Live Dynamic Imaging of Caveolae Pumping Targeted Antibody Rapidly and Specifically across Endothelium in the Lung","volume":"25","author":"Oh","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2023.114868_b0610","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/tra.12533","article-title":"Transcellular Vesicular Transport in Epithelial and Endothelial Cells: Challenges and Opportunities","volume":"19","author":"Fung","year":"2018","journal-title":"Trafc"},{"key":"10.1016\/j.addr.2023.114868_b0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121074","article-title":"Endogenous dual stimuli-activated NO generation in the conventional outflow pathway for precision glaucoma therapy","volume":"277","author":"Fan","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2023.114868_b0620","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bbrc.2017.09.065","article-title":"Cationization Increases Brain Distribution of An Amyloid-Beta Protofbril Selective F(ab\u2019)2 Fragment","volume":"493","author":"Syvanen","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.addr.2023.114868_b0625","doi-asserted-by":"crossref","first-page":"119902","DOI":"10.1016\/j.biomaterials.2020.119902","article-title":"Tumor Extravasation and Infiltration as Barriers of Nanomedicine for High Efficacy: The Current Status and Transcytosis Strategy","volume":"240","author":"Zhao","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2023.114868_b0630","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41565-019-0485-z","article-title":"Enzyme-Activatable Polymer-Drug Conjugate Augments Tumor Penetration and Treatment Efficacy","volume":"14","author":"Zhou","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.addr.2023.114868_b0635","doi-asserted-by":"crossref","first-page":"16929","DOI":"10.1021\/acsnano.0c05977","article-title":"Macromolecular Platform with Super-Cation Enhanced Trans-Cornea Infiltration for Noninvasive Nitric Oxide Delivery in Ocular Therapy","volume":"12","author":"Jia","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2023.114868_b0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121074","article-title":"Endogenous dual stimuli-activated NO generation in the conventional outflow pathway for precision glaucoma therapy","volume":"277","author":"Fan","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2023.114868_b0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121361","article-title":"Glycopeptide-nanotransforrs eyedrops with enhanced permeability and retention for preventing fundus neovascularization","volume":"281","author":"Li","year":"2022","journal-title":"Biomaterials"}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X23001837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X23001837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T05:38:39Z","timestamp":1759210719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X23001837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":129,"alternative-id":["S0169409X23001837"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2023.114868","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trans-corneal drug delivery strategies in the treatment of ocular diseases","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2023.114868","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114868"}}